APP and Alzheimer disease: One hypothesis holds that the aggregation of amyloid β-peptide (Aβ) (involved in synaptic formation and repair) into plaques is the executor of AD [48], which has also been genetically linked to familial AD cases in which mutations in the APP gene lead to increased amounts of Aβ [49].